C. Desuzinges

A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients

Anne‐Laure Giraudet, Philippe A. Cassier, Chicaco Iwao-Fukukawa et al. · BMC Cancer · 2018 · 65 citations · Full text

Is [18F]-2-fluoro-2-deoxy-d-glucose (FDG) scintigraphy with non-dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable radioiodine uptake?

Francesco Giammarile, Zakia Hafdi, Claire Bournaud et al. · European Journal of Endocrinology · 2003 · 49 citations

Europium and samarium as labels in time-resolved immunofluorometric assay of follitropin.

R. Bador, H. Déchaud, Francine Claustrat et al. · Clinical Chemistry · 1987 · 40 citations

Immunocytochemical Technique, Laboratory Immunology, Immunology +17

Assessment of osteosarcoma response to neoadjuvant chemotherapy: comparative usefulness of dynamic gadolinium-enhanced spin-echo magnetic resonance imaging and technetium-99 m skeletal angioscintigraphy

Pierre Ongolo‐Zogo, P. Thiesse, J. Sau et al. · European Radiology · 1999 · 32 citations

Bone Imaging, Neoadjuvant Chemotherapy, Medical Imaging +13

Chemotherapy for spinal cord astrocytoma

Éric Bouffet, D. Amat, Yves Devaux et al. · Medical and Pediatric Oncology · 1997 · 28 citations